CAY10464

CAS No. 688348-37-0

CAY10464( —— )

Catalog No. M37540 CAS No. 688348-37-0

CAY10464 (AHR antagonist 7) is a potent AHR antagonist with potential antitumor activity that inhibits CYP1A1 mRNA expression and may be used to study cancer and metabolic diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 61 In Stock
25MG 123 In Stock
50MG 198 In Stock
100MG 296 In Stock
200MG Get Quote In Stock
500MG 706 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CAY10464
  • Note
    Research use only, not for human use.
  • Brief Description
    CAY10464 (AHR antagonist 7) is a potent AHR antagonist with potential antitumor activity that inhibits CYP1A1 mRNA expression and may be used to study cancer and metabolic diseases.
  • Description
    CAY10464 (AHR antagonist 7) is a potent AHR antagonist with potential antitumor activity that inhibits CYP1A1 mRNA expression and may be used to study cancer and metabolic diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    AhR
  • Recptor
    AhR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    688348-37-0
  • Formula Weight
    279.16
  • Molecular Formula
    C15H12Cl2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/C1=CC(Cl)=CC(Cl)=C1)\C2=CC=C(OC)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • WAY-605471

    WAY-605471 is a AHR antagonist with IC50 of 0.5 - 1 μM.

  • AHR Inhibitor I-103

    AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.

  • 3-Methylindole

    Skatole is produced by intestinal bacteria regulates intestinal epithelial cellular functions through activating aryl hydrocarbon receptors and p38.